Fredrik Bäckström
Keine laufenden Positionen mehr
Vermögen: 33 957 $ am 31.03.2024
Profil
Fredrik Bäckström worked as the Vice President-Product Supply at Arcam AB from 2013 to 2019.
He also held the position of Vice President-Manufacturing & Supply at Carmel Pharma AB from 2000 to 2011.
Currently, he is serving as the Chief Operating Officer at Bulten AB, a position he started in 2019 and will continue until 2023.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BULTEN AB
0,02% | 25.08.2023 | 4 940 ( 0,02% ) | 33 957 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Fredrik Bäckström
| Unternehmen | Position | Ende |
|---|---|---|
| BULTEN AB | Chief Operating Officer | 01.08.2023 |
| ARCAM AB (PUBL) | Corporate Officer/Principal | 01.12.2019 |
Carmel Pharma AB
 Carmel Pharma AB Electronic Equipment/InstrumentsElectronic Technology Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BULTEN AB | Producer Manufacturing |
| Private Unternehmen | 2 |
|---|---|
Arcam AB
 Arcam AB Industrial MachineryProducer Manufacturing Arcam AB engages in the development and commercialization of technologies for metal-based, freedom-in-design manufacturing. It develops, manufactures, and sells equipment and methods for Additive Manufacturing in metal. The company was founded in 1997 and is headquartered in Molndal, Sweden. | Producer Manufacturing |
Carmel Pharma AB
Carmel Pharma AB Electronic Equipment/InstrumentsElectronic Technology Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden. | Electronic Technology |
